introduct
bacteri
infect
lead
caus
death
children
global
clinic
algorithm
identifi
children
like
benefit
antimicrobi
treatment
remain
suboptim
biomark
accur
identifi
seriou
bacteri
infect
sbi
could
improv
diagnosi
clinic
manag
lipocalin
neutrophil
collagenas
neutrophilderiv
biomark
associ
bacteri
infect
method
evalu
candid
biomark
healthi
control
febril
children
categoris
confirm
sbi
probabl
sbi
viral
infect
diagnost
perform
predict
sbi
estim
area
receiv
oper
characterist
curv
auroc
compar
perform
creactiv
protein
crp
result
plasma
concentr
predict
sbi
auroc
ci
crp
predict
sbi
respect
diagnost
perform
combin
crp
significantli
superior
either
marker
alon
auroc
ci
conclus
sensit
specif
predictor
sbi
children
could
use
improv
clinic
manag
antimicrobi
stewardship
evalu
prospect
clinic
studi
correspond
ccasal
cliniccat
introduct
bacteri
infect
remain
major
infecti
caus
death
children
identifi
small
number
children
seriou
bacteri
infect
sbi
microbiolog
confirm
bacteri
infect
system
symptom
amongst
major
viral
infect
remain
difficult
clinic
featur
unreli
laboratori
marker
includ
white
cell
count
neutrophil
proport
creactiv
protein
crp
strongest
predict
valu
children
clinic
obviou
sbi
rather
numer
group
clinic
uncertain
infect
statu
blood
cultur
consid
gold
standard
diagnos
sbi
unhelp
earli
antibiot
decis
result
immedi
avail
often
neg
preadmiss
antibiot
administ
uk
increas
hospit
admiss
children
probabl
infect
major
children
admit
fever
discharg
without
pathogen
diagnosi
mani
children
selflimit
viral
ill
admit
hospit
receiv
unnecessari
antibiot
whilst
await
result
cultur
contribut
tabl
demograph
clinic
data
recruit
subject
tabl
footnot
ns
signific
p
iqr
interquartil
rang
na
applic
picupaediatr
intens
care
unit
wbc
white
cell
count
patient
sampl
collect
virolog
investig
b
patient
respiratori
nonrespiratori
virus
detect
identifi
bacterium
list
patient
definit
bacteri
infect
two
age
comparison
signific
probabl
bacteri
median
age
higher
definit
viral
group
p
definit
viral
group
younger
control
p
proport
children
male
sex
caucasian
ethnic
mode
ethnic
significantli
differ
group
sever
ill
indic
number
children
requir
picu
admiss
inotrop
use
ventil
highest
definit
bacteri
group
lowest
definit
viral
group
death
group
significantli
differ
spread
antibiot
resist
urgent
need
new
biomark
reliabl
identifi
sbi
identifi
neutrophil
gelatinaseassoci
lipocalin
ngal
neutrophil
collagenas
matrix
potenti
protein
candid
distinguish
bacteri
pneumonia
viral
pneumonia
african
children
valid
diagnost
perform
marker
cohort
uk
children
confirm
probabl
possibl
sbi
versu
viral
infect
healthi
control
test
studi
approv
st
mari
research
ethic
committe
rec
written
inform
consent
obtain
pathogen
diagnosi
bacteri
diagnost
includ
cultur
blood
clinic
indic
cerebrospin
pleural
fluid
pneumococc
antigen
detect
blood
urin
respiratori
nasopharyng
secret
screen
virus
nest
pcr
includ
rsv
coronaviru
adenoviru
parainfluenza
influenza
ab
bocaviru
metapneumoviru
rhinoviru
patient
categoris
select
patient
assign
clinic
categori
correspond
likelihood
infect
evalu
clinic
radiolog
laboratori
data
figur
patient
categori
definit
bacteri
db
probabl
bacteri
pb
uncertain
bacteri
viral
u
probabl
viral
pv
definit
viral
dv
db
children
microbiolog
confirm
bacteri
infect
identifi
sterilesit
irrespect
crp
valu
patient
pv
categori
analysi
carri
group
control
c
recruit
outpati
categoris
patient
prioritis
biomark
estim
base
quantiti
avail
plasma
chronolog
order
recruit
give
group
follow
db
pb
u
v
c
biomark
measur
heparinis
blood
sampl
kept
pend
plasma
recoveri
centrifug
storag
measur
use
commerci
avail
immunoassay
rd
system
uk
follow
manufactur
instruct
laboratori
personnel
blind
diagnost
group
sampl
presenc
visibl
haemolysi
number
previou
plasma
freezethaw
cycl
prior
eia
systemat
effect
measur
coeffici
variat
measur
calcul
sampl
replic
crp
creatinin
valu
contemporari
research
blood
sampl
obtain
hospit
data
children
crp
measur
elisa
control
rd
system
uk
statist
analys
diagnost
perform
clinic
marker
assess
use
area
receiv
oper
characterist
auroc
curv
compar
sensit
specif
select
marker
cutoff
valu
chosen
base
highest
sensit
specif
predict
outcom
supplementari
tabl
diagnost
perform
biomark
assess
logist
regress
use
crp
independ
variabl
condit
diagnos
depend
variabl
chisquar
statist
use
test
equal
auroc
stata
stata
corpor
laboratori
measur
age
patient
group
compar
use
kruskalw
test
dunn
pairwis
comparison
frequenc
variabl
includ
sex
ethnic
sever
ill
compar
use
fisher
exact
chisquar
test
independ
use
prism
graphpad
softwar
inc
result
patient
group
tabl
show
demograph
featur
patient
group
ethnic
gender
differ
significantli
children
dv
group
younger
pb
c
group
expect
viral
respiratori
infect
proport
children
sever
ill
higher
db
dv
group
associ
sbi
concentr
plasma
lowest
control
increas
stepwis
likelihood
sbi
tabl
crp
discrimin
patient
db
dv
c
group
figur
deriv
roc
curv
crp
patient
neutrophil
proport
white
cell
count
patient
avail
valu
base
comparison
db
group
febril
patient
combin
pb
u
dv
group
figur
use
continu
variabl
predict
confirm
sbi
auroc
ci
match
auroc
crp
ci
neutrophil
proport
white
cell
count
predict
confirm
sbi
less
well
crp
auroc
respect
figur
perform
confound
creatinin
concentr
level
increas
renal
damag
determin
whether
renal
impair
influenc
diagnost
perform
creatinin
level
contemporan
research
blood
avail
children
median
iqr
significantli
differ
clinic
group
kruskalw
adjust
logist
regress
analysi
indic
predict
sbi
affect
creatinin
concentr
supplementari
tabl
combin
crp
predict
sbi
crp
use
benchmark
evalu
perform
predict
confirm
sbi
patient
avail
crp
data
auroc
crp
strongli
associ
confirm
sbi
biomark
highli
correl
r
p
howev
protein
includ
logist
regress
model
combin
significantli
superior
either
marker
alon
auroc
ci
figur
supplementari
tabl
crp
uncertain
cohort
without
sensit
goldstandard
test
detect
sbi
major
sbi
miss
therefor
correl
crp
biomark
concentr
clinic
suspicion
sbi
stepwis
increas
biomark
concentr
increas
suspicion
sbi
c
dv
u
pb
b
tabl
figur
deriv
cutoff
valu
crp
base
concentr
show
highest
sensit
specif
discrimin
confirm
bacteri
infect
db
febril
patient
supplementari
tabl
sensit
specif
predict
db
crp
sensit
specif
threshold
valu
appli
group
stepwis
increas
predict
sbi
c
dv
u
pb
sensit
specif
marker
combin
equal
greater
decil
children
admit
acut
infect
sick
enough
warrant
blood
test
recruit
present
diagnost
studi
complet
st
mari
hospit
london
univers
hospit
nh
foundat
trust
southampton
uk
detail
clinic
laboratori
data
record
healthi
control
recruit
outpati
exclud
patient
proven
possibl
inflammatori
condit
mycobacteri
diseas
two
independ
paediatr
infecti
diseas
clinician
access
clinic
diagnost
data
categoris
patient
follow
children
clinic
syndrom
keep
sbi
sepsi
shock
sever
focal
infect
categoris
definit
bacteri
db
pathogen
bacteria
detect
usual
steril
site
blood
csf
includ
surfac
swab
endotrach
secret
bronchoalveolar
lavag
sampl
otherwis
patient
categoris
probabl
bacteri
pb
children
clinic
syndrom
keep
viral
infect
display
bacteri
featur
categoris
definit
viral
dv
match
viru
identifi
otherwis
probabl
viral
pv
children
without
detect
sterilesit
bacteria
inconclus
clinic
featur
viral
bacteri
infect
classifi
uncertain
u
set
threshold
maximum
crp
minimum
inclus
pb
group
maximum
inclus
pv
dv
group
inclus
db
group
irrespect
crp
patient
fail
crp
threshold
categoris
uncertain
u
alongsid
patient
group
inconclus
clinic
featur
control
c
current
recent
previou
two
week
infecti
symptom
immunis
identifi
probabl
chronic
infecti
inflammatori
condit
crp
creactiv
protein
wcc
white
cell
count
discuss
studi
show
sensit
specif
biomark
associ
sbi
children
febril
ill
potenti
guid
antibiot
treatment
decis
best
diagnost
perform
achiev
combin
crp
auroc
glycoprotein
secret
neutrophil
hepatocyt
renal
tubular
cell
usual
found
low
concentr
ngml
biolog
fluid
role
innat
defenc
bacteri
infect
attribut
abil
interfer
bacteri
iron
uptak
competit
bacteri
siderophor
enterobactin
role
potenti
marker
bacteri
infect
describ
previou
studi
similarli
gene
express
shown
discrimin
bacteri
viral
infect
increas
express
bacteri
patient
compar
control
un
like
crp
diagnost
perform
unaffect
age
gene
express
central
immunemetabol
network
implic
neonat
bacteri
infect
comparison
crp
much
shorter
halflif
minut
rise
rapidli
crp
studi
neonat
respond
rapidli
success
antibiot
treatment
although
fast
turnov
desir
qualiti
biomark
monitor
infect
treatment
also
diagnost
limit
patient
receiv
prior
antibiot
treatment
time
diagnosi
recent
emerg
biomark
acut
kidney
injuri
investig
associ
sbi
confound
impair
renal
function
adjust
analysi
creatinin
concentr
affect
diagnost
perform
predict
sbi
suggest
neutrophil
like
sourc
diagnost
perform
exceed
previous
propos
paediatr
sepsi
biomark
studi
defin
patient
group
gradient
lowto
high
likelihood
sbi
advantag
captur
real
world
situat
major
patient
definit
confirm
exclud
infect
clinic
group
like
sbi
defin
posit
blood
cultur
gold
standard
use
variabl
predict
outcom
evalu
diagnost
perform
thu
possibl
compar
diagnost
valu
gold
standard
instead
use
crp
comparison
measur
biomark
guid
antibiot
treatment
commonli
use
secondari
tertiari
care
shown
biomark
concentr
proport
estim
likelihood
sbi
unconfirm
patient
tend
intermedi
level
pb
group
ngml
threshold
compar
level
crp
group
diagnost
uncertainti
comparison
would
confound
use
crp
result
alloc
patient
clinic
group
pb
u
dv
procalcitonin
promis
biomark
bacteri
infect
kinet
compar
shown
modest
advantag
crp
predict
sbi
data
comparison
unless
biomark
identifi
discrimin
sbi
nonsbi
patient
nonoverlap
concentr
children
intermedi
grey
clinic
marker
bacteri
infect
remain
group
biomark
least
effect
need
potenti
alon
combin
crp
improv
rapid
identif
children
sbi
earli
time
cultur
result
avail
could
benefit
clinic
decisionmak
children
present
febril
ill
improv
antibiot
coverag
easili
miss
minor
children
sbi
potenti
improv
antibiot
manag
decis
febril
children
evalu
clinic
trial
supplementari
tabl
sensit
specif
crp
combin
crp
supplementari
